Published in:
01-12-2022 | COVID-19 | Research
Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?
Authors:
Istemi Serin, Nagehan Didem Sari, Murat Gunaltili, Ayse Karakilic, Begum Gulesir, Beyza Kal Kolik, Gulnihal Cevik, Hilal Sungurlu, Melike Keskin, Muhammed Baltik, Onurhan Cakmak, Tahir Alper Cinli
Published in:
BMC Infectious Diseases
|
Issue 1/2022
Login to get access
Abstract
Background
Severe inflammation and one or more extrapulmonary organ dysfunctions have been reported and this clinical picture is defined as "multisystem inflammatory syndrome in adults" (MIS-A) in severe coronavirus disease-2019 (COVID-19). We aimed to determine the effect of LDH/lymphocyte ratio (LLR) on the development of MIS-A.
Methods
The data of 2333 patients were retrospectively analyzed.
Results
MIS-A rate was found to be 9.9% and MIS-A related mortality was 35.3%. LRR level above 0.24 was found to predict MIS-A development with 70% sensitivity and 65.2% specificity. The risk of MIS-A development was found to be 3.64 times higher in those with LRR levels above 0.24 compared to those with 0.24 and below. In patients with MIS-A, LRR level above 0.32 predicts mortality with 78% sensitivity and 70% specificity.
Conclusions
Early detection of MIS-A with high sensitivity and specificity in a practical ratio is very important in terms new studies.